What the English source shows.
- Evidence group
- Pilot studies
- Journal
- JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY, 2013, 6(10):23-26)
- English PDF
- Page 54
Abstract focus
The positive preliminary outcomes from this pilot study suggest a randomized, double-blind, clinical trial would be worthwhile in evaluating whether this protein isolate would result in statistically significant improvement for patients with psoriasis.
Context from Dr. Gutman’s comments
A small group of psoriatic patients in the Washington area was fed Immunocal to see what clinical benefits could be measured on a standard psoriasis severity score. They also compared photographs of affected skin.
How to use this study responsibly
- Read it according to its evidence group, not as a universal product promise.
- Use the English PDF to verify the abstract and commentary directly.
- For medical conditions, treatment, pregnancy, breastfeeding or medication, speak with a qualified healthcare professional.